EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Assessing the Outcomes and Complications of Skin Allografts in Healing Diabetic Foot and Venous Leg Ulcers: A Systematic Review of Randomised Controlled Trials

Christopher Mathe iD, Sachin Reddi iD, William Nahm iD, Aryaman Trikala iD, Samuel Schwartz

International Wound Journal · 2026-06 · 23 (6)

DOI: 10.1111/iwj.70892 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Wound Journal, online erschienen am 04.06.2026. Verfasst von Christopher Mathe und 4 weiteren Autor:innen. Beteiligte Einrichtung: California University of Science and Medicine, Colton, California, USA. Hauptthemen laut MEDLINE: Wound Healing, Skin Transplantation, Diabetic Foot, Allografts. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic diabetic foot ulcers and venous leg ulcers remain difficult to treat due to delayed healing and high complication rates. Biologic skin allografts derived from living or amniotic tissue provide extracellular matrix components, cytokines, growth factors and viable cells that facilitate tissue repair. This investigation systematically reviewed randomised controlled trials comparing Apligraf, Theraskin, Amnioband, Amnioexcel, EpiCord and Epifix for chronic lower extremity wounds. Searches were conducted in PubMed, Embase and Cochrane databases. Primary outcomes included complete wound closure at 12 weeks, time to healing and percent area reduction. Secondary outcomes included infection, amputation and recurrence rates. Nineteen trials with a total of 1303 participants met inclusion criteria. Analysis demonstrated statistical significance in 12‐week wound closure ( p = 0.0394), with Theraskin achieving the highest mean closure (84.7%) and Amnioexcel the lowest (37.5%). Epifix and Amnioband showed faster healing trends and greater closure advantages compared with standard care. Reported complications were uncommon and inconsistently defined. While no single graft demonstrated statistically superior outcomes, descriptive trends suggest Theraskin, Epifix and Amnioband may offer greater clinical benefit. These findings provide comparative insight to guide clinical selection of skin substitutes and highlight the need for large‐scale head‐to‐head trials to establish relative efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingSkin TransplantationDiabetic FootAllograftsVaricose UlcerSkin, ArtificialHumansRandomized Controlled Trials as TopicFemaleMaleTreatment OutcomeMiddle AgedAged

Stichwörter der Autor:innen

allograftartificial skindiabetic foot ulcervenous leg ulcerwound healing

Autor:innen und Institutionen

  • California University of Science and Medicine, Colton, California, USA.
  • NYU Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Christopher Mathe, Sachin Reddi, William Nahm, Aryaman Trikala

Zitieren

APA

Mathe, C., Reddi, S., Nahm, W., Trikala, A., & Schwartz, S. (2026). Assessing the Outcomes and Complications of Skin Allografts in Healing Diabetic Foot and Venous Leg Ulcers: A Systematic Review of Randomised Controlled Trials. International Wound Journal, 23(6). https://doi.org/10.1111/iwj.70892

Vancouver

Mathe C, Reddi S, Nahm W, Trikala A, Schwartz S. Assessing the Outcomes and Complications of Skin Allografts in Healing Diabetic Foot and Venous Leg Ulcers: A Systematic Review of Randomised Controlled Trials. International Wound Journal. 2026;23(6). doi:10.1111/iwj.70892

BibTeX
@article{Mathe2026,
  author = {Mathe, Christopher and Reddi, Sachin and Nahm, William and Trikala, Aryaman and Schwartz, Samuel},
  title = {Assessing the Outcomes and Complications of Skin Allografts in Healing Diabetic Foot and Venous Leg Ulcers: A Systematic Review of Randomised Controlled Trials},
  journal = {International Wound Journal},
  year = {2026},
  volume = {23},
  number = {6},
  doi = {10.1111/iwj.70892}
}
Kostenlos starten →